Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1

Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1

Bibliographic Details
Main Authors: Julius Lukes, Jr., Lucie Winkowska, Martina Zwyrtkova, Julia Starkova, Lucie Sramkova, Jan Stary, Jan Trka, Jan Zuna, Marketa Zaliova
Format: Article
Language:English
Published: Wolters Kluwer 2020-12-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000489

Internet

http://journals.lww.com/10.1097/HS9.0000000000000489

Similar Items